Javascript must be enabled to continue!
Analysis of human t cell and b cell responses against u small nuclear ribonucleoprotein 70‐kd, b, and d polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease
View through CrossRef
AbstractObjective. To analyze T and B cell reactivity with U small nuclear RNP (snRNP) 70‐kd, B, and D polypeptides among patients with connective tissue disease (CTD) and to examine the functional characteristics of snRNP‐reactive T cell clones.Methods. We used an snRNP enzyme‐linked immunosorbent assay and immunoblotting to characterize antibodies in patients' sera. We used human recombinant fusion proteins 70 kd, B, and D to stimulate and clone snRNP‐reactive T cells from CTD patients. We analyzed the cell surface phenotype, antigenic specificity, and cytokine profiles of T cell clones.Results. Patients showed T cell responsiveness to snRNP polypeptides that paralleled their autoantibody reactivities. A total of 256 clones were generated, and clones were identified which were specific for the 70‐kd, B, or D polypeptides. Clones expressed a T helper cell phenotype, and were found to produce substantial quantities of both interleukin‐4 (IL‐4) and interferon‐γ, and lesser quantities of IL‐2 and IL‐6.Conclusion. These results show that CTD patients have clonable circulating snRNP‐reactive T cells that parallel the specificity of snRNP‐reactive antibodies in their sera. The snRNP‐reactive T cells exhibit a helper cell phenotype and produce cytokines which are important in B cell help and differentiation.
Title: Analysis of human t cell and b cell responses against u small nuclear ribonucleoprotein 70‐kd, b, and d polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease
Description:
AbstractObjective.
To analyze T and B cell reactivity with U small nuclear RNP (snRNP) 70‐kd, B, and D polypeptides among patients with connective tissue disease (CTD) and to examine the functional characteristics of snRNP‐reactive T cell clones.
Methods.
We used an snRNP enzyme‐linked immunosorbent assay and immunoblotting to characterize antibodies in patients' sera.
We used human recombinant fusion proteins 70 kd, B, and D to stimulate and clone snRNP‐reactive T cells from CTD patients.
We analyzed the cell surface phenotype, antigenic specificity, and cytokine profiles of T cell clones.
Results.
Patients showed T cell responsiveness to snRNP polypeptides that paralleled their autoantibody reactivities.
A total of 256 clones were generated, and clones were identified which were specific for the 70‐kd, B, or D polypeptides.
Clones expressed a T helper cell phenotype, and were found to produce substantial quantities of both interleukin‐4 (IL‐4) and interferon‐γ, and lesser quantities of IL‐2 and IL‐6.
Conclusion.
These results show that CTD patients have clonable circulating snRNP‐reactive T cells that parallel the specificity of snRNP‐reactive antibodies in their sera.
The snRNP‐reactive T cells exhibit a helper cell phenotype and produce cytokines which are important in B cell help and differentiation.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
The impaired suppressive function of regulatory T cells is well-understood in systemic lupus erythematosus. This is likely due to changes in Foxp3 expression that are crucial for r...
BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS
BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS
Systemic Lupus Erythematosus is an autoimmune multisystem pathology, characterized by being more prevalent in women, especially African women. One of the most frequent pathologies ...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Histology of Skin Alterations in Lupus Erythematosus
Histology of Skin Alterations in Lupus Erythematosus
Abstract
Lupus erythematosus is an autoimmune connective tissue disorder showing a broad spectrum of clinical manifestations.
The a...

